Episode

Ep 257: Peptide Medicine & the Future of Health — A Conversation with Ted McGill

Podcast
Fitness Education Online Podcast I For Personal Trainers, Fitness Professionals, Gym Owners & the Fitness Industry
Published
Oct 23, 2025
Duration seconds
4283
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/1831309/episodes/18061135-ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill.mp3
Audio
https://www.buzzsprout.com/1831309/episodes/18061135-ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill.mp3
JSON
/v1/public/podcasts/fitness-education-online-podcast-i-for-personal-trainers-fitness-professionals-gym-owners-the-fitness-industry-329324/episodes/ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill
Markdown
/podcast/fitness-education-online-podcast-i-for-personal-trainers-fitness-professionals-gym-owners-the-fitness-industry-329324/ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/fitness-education-online-podcast-i-for-personal-trainers-fitness-professionals-gym-owners-the-fitness-industry-329324/episodes/ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/fitness-education-online-podcast-i-for-personal-trainers-fitness-professionals-gym-owners-the-fitness-industry-329324/ep-257-peptide-medicine-the-future-of-health-a-conversation-with-ted-mcgill.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Episode Summary: In this episode, Travis speaks with Ted McGill, founder of Biov8, a company specialising in peptide therapeutics and advanced health solutions. The discussion explores the emerging field of peptide medicine — what peptides are, how they work, and the evidence behind their various applications. Ted shares insights on peptide use and efficacy, how they relate to GLP-1 medications, and why uptake among medical professionals has been relatively slow despite promising result...